Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    hokusai
Show Display Options
Rank Status Study
1 Completed
Has Results
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Thromboembolism;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b);   Drug: low molecular weight heparin/unfractionated heparin;   Drug: warfarin
2 Not yet recruiting Hokusai VTE Pediatric Study
Conditions: Venous Thromboembolism;   Pulmonary Embolism
Interventions: Drug: Edoxaban 60 mg and dosing on mg/kg basis;   Drug: Warfarin dosed at INR level and mg/kg basis;   Drug: Enoxaparin dosed at INR level and mg/kg basis;   Drug: Fondaparinux dosed at INR level and mg/kg basis;   Drug: Edoxaban 45 mg and dosing on mg/kg basis

Indicates status has not been verified in more than two years